Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Outcomes for B-Precursor Patients in Legacy Children’s Cancer Group (CCG) and Pediatric Oncology Group (POG) Studies in Childhood Acute Lymphoblastic Leukemia (ALL): A Children’s Oncology Group (COG) Report.

Paul S. Gaynon, MD, Bruce C. Camitta, MD, Yousif Matloub, MD, Paul L. Martin, MD, Naomi Winick, MD, Nita L. Seibel, MD, W. Paul Bowman, MD, Harland N. Sather, PhD, Meenakshi Devidas, PhD, Stephen Hunger, MD, William L. Carroll, MD

Blood (2007) 110 (11): 847.

https://doi.org/10.1182/blood.V110.11.847.847

Published: 2007

Journal Articles

Outcomes in Children and Adolescents with a Markedly Elevated White Blood Cell Count (>200,000) at Diagnosis of High Risk Acute Lymphoblastic Leukemia (ALL): A Report from the Children’s Oncology Group.

Caroline Hastings, MD, Harland N. Sather, PhD, Nita L. Seibel, MD, James Nachman, MD, Peter G. Steinherz, MD, Kathy Bertolone, FNP, Cynthia DeLaat, MD, Lawrence J. Ettinger, MD, Janet Franklin, MD, David Robert Freyer, DO, Leonard A. Mattano, MD, Torrey L. Mitchell, MD, Charles M. Rubin, MD, Allan F. Pyesmany, MD, Nyla A. Heerema, PhD, Cheryl Edens, Paul S. Gaynon, MD

Blood (2006) 108 (11): 1870.

https://doi.org/10.1182/blood.V108.11.1870.1870

Published: 2006

Journal Articles

A SERPINE1 ( PAI-1 ) Single Nucleotide Polymorphism Predicts Osteonecrosis in Children Treated for Acute Lymphoblastic Leukemia: Results of the Children’s Oncology Group (COG) Study AALL03B2.

Leo H. Hamilton, MD, Leonard A. Mattano, MD, Harland N. Sather, PhD, Mary V. Relling, PharmD

Blood (2006) 108 (11): 709.

https://doi.org/10.1182/blood.V108.11.709.709

Published: 2006

Journal Articles

Gene Signatures Predictive of Outcome in Higher Risk Childhood Acute Lymphoblastic Leukemia (ALL).

Naomi P. Moskowitz, MD, Deepa Bhojwani, MD, Huining Kang, PhD, Dong-Joon Min, PhD, Jeffrey Potter, PhD, Richard Harvey, PhD, Nita L. Seibel, MD, Elizabeth Raetz, MD, Harland N. Sather, PhD, Stephen P. Hunger, MD, Cheryl L. Willman, MD, William L. Carroll, MD

Blood (2005) 106 (11): 1449.

https://doi.org/10.1182/blood.V106.11.1449.1449

Published: 2005

Journal Articles

Early Marrow Response in CCG-1952: The Prognostic Impact of Poor Day 14 Marrow Response Is Powerful and Only Partially Reversible with Intensified Therapy.

Robert Cho, MD, Linda C. Stork, MD, Paul S. Gaynon, MD, Harland N. Sather, PhD, Mei K. La, MS, Raymond J. Hutchinson, MD

Blood (2005) 106 (11): 867.

https://doi.org/10.1182/blood.V106.11.867.867

Published: 2005

NARROW

Outcomes for B-Precursor Patients in Legacy Children’s Cancer Group (CCG) and Pediatric Oncology Group (POG) Studies in Childhood Acute Lymphoblastic Leukemia (ALL): A Children’s Oncology Group (COG) Report.

Outcomes in Children and Adolescents with a Markedly Elevated White Blood Cell Count (>200,000) at Diagnosis of High Risk Acute Lymphoblastic Leukemia (ALL): A Report from the Children’s Oncology Group.

A SERPINE1 ( PAI-1 ) Single Nucleotide Polymorphism Predicts Osteonecrosis in Children Treated for Acute Lymphoblastic Leukemia: Results of the Children’s Oncology Group (COG) Study AALL03B2.

Gene Signatures Predictive of Outcome in Higher Risk Childhood Acute Lymphoblastic Leukemia (ALL).

Early Marrow Response in CCG-1952: The Prognostic Impact of Poor Day 14 Marrow Response Is Powerful and Only Partially Reversible with Intensified Therapy.

Email alerts

ASH Publications

American Society of Hematology

Outcomes for B-Precursor Patients in Legacy Children’s Cancer Group (CCG) and Pediatric Oncology Group (POG) Studies in Childhood Acute Lymphoblastic Leukemia (ALL): A Children’s Oncology Group (COG) Report.

Outcomes in Children and Adolescents with a Markedly Elevated White Blood Cell Count (>200,000) at Diagnosis of High Risk Acute Lymphoblastic Leukemia (ALL): A Report from the Children’s Oncology Group.

A SERPINE1 ( PAI-1 ) Single Nucleotide Polymorphism Predicts Osteonecrosis in Children Treated for Acute Lymphoblastic Leukemia: Results of the Children’s Oncology Group (COG) Study AALL03B2.

Gene Signatures Predictive of Outcome in Higher Risk Childhood Acute Lymphoblastic Leukemia (ALL).

Early Marrow Response in CCG-1952: The Prognostic Impact of Poor Day 14 Marrow Response Is Powerful and Only Partially Reversible with Intensified Therapy.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only